EC | HEALTHCARE

Seattle Genetics is an emerging global multi-product biotechnology company that develops and commercializes innovative antibody-based therapies for the treatment of cancer. The company’s industry-leading antibody-drug conjugate (ADC) technology harnesses the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. Seattle Genetics is preparing to launch tucatinib, a highly selective tyrosine kinase inhibitor (TKI), for HER2+ metastatic breast cancer patients in Europe. In this role, you will lead development of the Market Access strategy in Germany, Austria and Switzerland (DACH) for the company’s oncology pipeline. Specifically, the Director, ...

We are currently hiring a market access Director for our dynamic Market Access team. The purpose of this role is the global development and implementation of Patient Access strategies and plans to ensure that one of our orphan disease assets, a Vifor pipeline product is available to patients with minimal barriers to adoption and at appropriate reimbursement. Your responsibilities will include: Support the development and execution of the market access and HEOR strategy for our asset on an international level, with focus on EU and Geo-expansion; Support with the development of compelling product value dossiers/messaging intra-country; ...

We are currently hiring our Vice President of Market Access Iron Deficiency for our dynamic Market Access team. In this role you will be a key player in the global development and implementation of Patient Access strategies and plans to ensure that Vifor’s diverse products in the Iron Deficiency space (oral, low-potency intravenous, high potency intravenous) are available to patients with minimal barriers to adoption and at appropriate reimbursement rates. ...